• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Scynexis Inc (NQ: SCYX )

    1.260 -0.030 (-2.33%)
    Streaming Delayed Price Updated: 9:51 AM EST, Nov 14, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Scynexis Inc

    < Previous 1 2 3 4 5 6 Next >
    Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now
    While the very concept of penny stocks to buy is treacherous, these analyst-backed ideas could be enticing for the smart speculator. 
    Via InvestorPlace
    Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
    Gainers 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    WBB Research Institute Webcast Highlighted the Need For a Global Response to Candida auris and Other Deadly Antimicrobial Resistant Pathogens
    Cranford, New Jersey--(Newsfile Corp. - May 19, 2023) - WBB Research Institute (WBBRI) hosted... 
    Via Newsfile
    SCYNEXIS: Q1 Earnings Insights
    Via Benzinga
    Looking Into SCYNEXIS's Return On Capital Employed
    Via Benzinga
    Scynexis Inc. (NASDAQ: SCYX) Leading the Way in Thursday Trading Based on Percentage Gain
    Via Investor Brand Network
    Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher
    U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    SCYNEXIS (NASDAQ: SCYX) Enters Into Exclusive Agreement with GSK (NYSE: GSK) to Continue Commercializing Brexafemme to Treat Fungal Infections
    SCYNEXIS, Inc. (NASDAQ: SCYX) operates as a biotechnology company, which is focused on the research and development of novel solutions 
    Via Spotlight Growth
    GSK Bets On Scynexis' FDA-Approved Antifungal Drug For Over $500M In Bio Bucks
    Via Benzinga
    SCYNEXIS's Return On Capital Employed Overview
    Via Benzinga
    Scynexis Looks For Commercial Partner For Its Lead Infection Treatment
    Via Benzinga
    Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront... 
    Via Benzinga
    Warner Music Layoffs: What to Know About the Latest WMG Job Cuts
    Warner Music (WMG) layoffs have the entertainment company cutting 4% of its workforce, or 270 jobs, during economic uncertainty. 
    Via InvestorPlace
    Why Is EVgo (EVGO) Stock Up 25% Today?
    EVgo (EVGO) stock is on the rise Thursday following the release of its earnings report for the fourth quarter of the year! 
    Via InvestorPlace
    Why Is Scynexis (SCYX) Stock Up 69% Today?
    Scynexis (SCYX) stock is taking off on Tuesday as investors react to news of an exclusive license agreement for Brexafemme. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Analyst Sees Multiple Chances With Over 300% Upside Potential For This Fungal Infections Stock
    Via Benzinga
    Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday. 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    We're starting off the week with an overview of the biggest pre-market stock movers traders need to know about for Monday! 
    Via InvestorPlace
    Stocks That Hit 52-Week Lows On Friday
      Friday's session saw 75 companies set new 52-week lows. 
    Via Benzinga
    Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
    October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
      On Wednesday, 258 companies hit new 52-week lows. 
    Via Benzinga
    Looking Into SCYNEXIS's Return On Capital Employed
    Benzinga Pro data, SCYNEXIS (NASDAQ:SCYX) reported Q2 sales of $1.32 million. Earnings fell to a loss of $13.35 million, resulting in a 144.82% decrease from last quarter. 
    Via Benzinga
    Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.